Dow Up 0.11% Nasdaq Up 0.50%

Agenus Inc. (AGEN)

-NasdaqCM
3.14 Down 0.01(0.32%) Aug 29, 4:00PM EDT
Prev Close:3.15
Open:3.16
Bid:2.94 x 100
Ask:3.58 x 5100
1y Target Est:5.75
Beta:2.16
Next Earnings Date:N/A
Day's Range:3.09 - 3.17
52wk Range:2.27 - 5.27
Volume:269,856
Avg Vol (3m):905,152
Market Cap:196.81M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 0.32%196.81M
ABPI 0.00%305.17K
DNDN 0.00%211.38M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):40.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.52
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback